Bone scan index rise prior to osteonecrosis of the jaw with bone‐modifying agents in prostate cancer

Abstract Objective This study aimed to evaluate the maximum bone scan index in the jaw (BSIJmax) before the development of clinical medication‐related osteonecrosis of the jaw (MRONJ) in patients with prostate cancer. Methods We retrospectively analysed 135 patients with prostate cancer and bone met...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Masaru Tani, Koji Hatano, Takashi Kamiya, Masatoshi Konishi, Atsuki Matsukawa, Hiromu Horitani, Syunsuke Inoguchi, Tomohiro Kanaki, Akihiro Yoshimura, Yuki Horibe, Yutong Liu, Nesrine Sassi, Toshiki Oka, Yohei Okuda, Gaku Yamamichi, Yu Ishizuya, Takuji Hayashi, Yoshiyuki Yamamoto, Taigo Kato, Tadashi Watabe, Atsunari Kawashima, Kayako Isohashi, Norio Nonomura
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2026-05-01
Serie:	BJUI Compass
Soggetti:	bone metastases bone‐modifying agent bone scan index bone scintigraphy denosumab mandible
Accesso online:	https://doi.org/10.1002/bco2.70212
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!